版本
5.0
创建日期
2005-11-16 15:48:42 UTC
更新日期
2021-09-14 15:20:01 UTC
登录号
HMDB0000023
地位
quantified
二级访问
HMDB0000435

HMDB00023

HMDB00435

HMDB0062640

HMDB0126088

HMDB62640

名称
(S)-3-Hydroxyisobutyric acid
描述
(S)-3-Hydroxyisobutyric acid (3-HIBA) (CAS: 2068-83-9) is an organic acid. 3-HIBA is an intermediate in L-valine metabolism. 3-HIBA plays an important role in the diagnosis of the very rare inherited metabolic diseases 3-hydroxyisobutyric aciduria (OMIM: 236795) and methylmalonic semialdehyde dehydrogenase deficiency (OMIM: 603178). Patients with 3-hydroxyisobutyric aciduria excrete a significant amount of 3-HIBA not only during the acute stage but also when stable. 3-Hydroxyisobutyric aciduria is caused by a 3-hydroxyisobutyryl-CoA dehydrogenase deficiency (PMID: 18329219). The severity of this disease varies from case to case. Most patients exhibit dysmorphic features, such as a small triangular face, a long philtrum, low set ears, and micrognathia (PMID: 10686279). Lactic acidemia is also found in the affected patients, indicating that mitochondrial dysfunction is involved. 3-HIBA appears to specifically inhibit the function of the respiratory chain complex I-III and mitochondrial creatine kinase (PMID: 18329219). BioTransformer predicts that 3-HIBA is a product of 2-methylpropanoic acid metabolism via a hydroxylation-of-terminal-methyl reaction catalyzed by CYP2B6 and CYP2E1 enzymes (PMID: 30612223).
同义词
1:(S)-3-Hydroxy-2-methylpropanoic acid

2:(S)-3-Hydroxy-2-methylpropionic acid

3:(S)-3-Hydroxy-2-methylpropanoate

4:(S)-3-Hydroxy-2-methylpropionate

5:(S)-3-Hydroxyisobutyrate

6:2-Methyl-L-(+)-hydracrylate

7:2-Methyl-L-(+)-hydracrylic acid

8:3-Hydroxy(iso)butyric acid

9:3-Hydroxy-2-methyl-(S)-propanoate

10:3-Hydroxy-2-methyl-(S)-propanoic acid

11:3-Hydroxy-2-methylpropanoate

12:3-Hydroxy-2-methylpropanoic acid

13:3-Hydroxy-isobutyrate

14:3-Hydroxyisobutyrate

15:3-Hydroxyisobutyric acid

16:(2S)-3-Hydroxy-2-methylpropanoic acid

17:(2S)-3-Hydroxy-2-methylpropionic acid

18:(S)-beta-Hydroxyisobutyric acid

19:(S)-Β-hydroxyisobutyric acid

20:(±)-3-hydroxy-2-methylpropanoic acid

21:(±)-3-hydroxy-2-methylpropionic acid

22:2-(Hydroxymethyl)propanoic acid

23:2-(Hydroxymethyl)propionic acid

24:2-Methyl-3-hydroxypropanoic acid

25:2-Methyl-3-hydroxypropionic acid

26:3-HIBA

27:3-Hydroxy-2-methylpropionic acid

28:DL-3-Hydroxyisobutyric acid

29:L-(+)-beta-Hydroxyisobutyric acid

30:L-(+)-Β-hydroxyisobutyric acid

31:beta-Hydroxyisobutyric acid

32:Β-hydroxyisobutyric acid

33:3-Hydroxy-2-isobutyrate

34:3-Hydroxy-2-isobutyric acid

35:(S)-3-Hydroxyisobutyric acid

化学式
C4H8O3
平均分子量
104.1045
等位分子量
104.047344122
化学名称
(2S)-3-hydroxy-2-methylpropanoic acid
传统名称
(S)-3-hydroxyisobutyric acid
CAS 登记号
26543-05-5
代谢物结构字符串
C[C@@H](CO)C(O)=O
inchi标识符
InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1
印记键
DBXBTMSZEOQQDU-VKHMYHEASA-N
分类学
description: belongs to the class of organic compounds known as beta hydroxy acids and derivatives. Beta hydroxy acids and derivatives are compounds containing a carboxylic acid substituted with a hydroxyl group on the C3 carbon atom.

description:Beta hydroxy acids and derivatives

kingdom:Organic compounds

super_class:Organic acids and derivatives

class:Hydroxy acids and derivatives

sub_class:Beta hydroxy acids and derivatives

molecular_framework:Aliphatic acyclic compounds

1:Carbonyl compounds

2:Carboxylic acids

3:Hydrocarbon derivatives

4:Monocarboxylic acids and derivatives

5:Organic oxides

6:Primary alcohols

7:Alcohol

8:Aliphatic acyclic compound

9:Beta-hydroxy acid

10:Carbonyl group

11:Carboxylic acid

12:Carboxylic acid derivative

13:Hydrocarbon derivative

14:Monocarboxylic acid or derivatives

15:Organic oxide

16:Organic oxygen compound

17:Organooxygen compound

18:Primary alcohol

19:3-hydroxyisobutyric acid

本体论
term:Physiological effect

definition:The effect on an organism physiology, resulting from its exposure to a chemical.

parent_id:

level:1

type:parent

term:Health effect

definition:A health condition or observation associated with a stimuli or with a biological activity of a chemical.

parent_id:7693

*level:2

type:parent

term:Health condition

definition:A health effect that consists on short or long-term disease, condition, disorder, syndrome or constant abnormality.

parent_id:7694

**level:3

type:parent

term:Diabetes mellitus type 2

definition:

parent_id:7695

***level:4

type:child

synonym:Non-insulin-dependent diabetes mellitus

synonym:Niddm

synonym:Adult-onset diabetes

term:Disposition

definition:A concept that describes the origin of a chemical, its location within an organism, or its route of exposure.

parent_id:

level:1

type:parent

term:Source

definition:Natural or synthetic origin of a chemical.

parent_id:7724

*level:2

type:parent

term:Endogenous

definition:

parent_id:7735

**level:3

type:child

term:Biological location

definition:The physiological origin within an organism, including anatomical compnents, biofluids and excreta.

parent_id:7724

*level:2

type:parent

term:Biofluid and excreta

definition:A liquid, semi-solid or solid material originating in the body.

parent_id:7725

**level:3

type:parent

term:Saliva

definition:The watery fluid in the mouth made by the salivary glands. saliva moistens food to help digestion and it helps protect the mouth against infections. (nci).

parent_id:7731

***level:4

type:child

term:Urine

definition:Excretion in liquid state processed by the kidney.

parent_id:7731

***level:4

type:child

term:Blood

definition:A liquid tissue with the primary function of transporting oxygen and carbon dioxide (nci). it supplies the tissues with nutrients, removes waste products, and contains various components of the immune system defending the body against infection.

parent_id:7731

***level:4

type:child

term:Cerebrospinal fluid

definition:The fluid that is contained within the brain ventricles, the subarachnoid space and the central canal of the spinal cord. (nci).

parent_id:7731

***level:4

type:child

synonym:Csf

term:Subcellular

definition:An anatomical organizational level including a component within a biological cell .

parent_id:7725

**level:3

type:parent

term:Cytoplasm

definition:The portion of the cell contained within the plasma membrane but excluding the nucleus.

parent_id:7730

***level:4

type:child

synonym:Cytoplasma

term:Mitochondria

definition:

parent_id:7730

***level:4

type:child

term:Process

definition:Biological or chemical events, or a series thereof, leading to a known function or end-product.

parent_id:

level:1

type:parent

term:Naturally occurring process

definition:Naturally-occurring molecular events or a series thereof, leading to a known function or end-product.

parent_id:7659

*level:2

type:parent

term:Biological process

definition:Biological or chemical events or a series thereof, leading to a known function or end-product within an organism.

parent_id:7660

**level:3

type:parent

term:Biochemical pathway

definition:A linked series of chemical reactions that occur in a defined order within or between organism cells, and lead to a known function or end product.

parent_id:7661

***level:4

type:parent

状态
Solid
实验性质
预测性质
1:

kind:logp

value:-0.47

source:ALOGPS

2:

kind:logs

value:0.74

source:ALOGPS

3:

kind:solubility

value:571 g/L

source:ALOGPS

4:

kind:logp

value:-0.26

source:ChemAxon

5:

kind:pka_strongest_acidic

value:4.37

source:ChemAxon

6:

kind:pka_strongest_basic

value:-2.7

source:ChemAxon

7:

kind:iupac

value:(2S)-3-hydroxy-2-methylpropanoic acid

source:ChemAxon

8:

kind:average_mass

value:104.1045

source:ChemAxon

9:

kind:mono_mass

value:104.047344122

source:ChemAxon

10:

kind:smiles

value:C[C@@H](CO)C(O)=O

source:ChemAxon

11:

kind:formula

value:C4H8O3

source:ChemAxon

12:

kind:inchi

value:InChI=1S/C4H8O3/c1-3(2-5)4(6)7/h3,5H,2H2,1H3,(H,6,7)/t3-/m0/s1

source:ChemAxon

13:

kind:inchikey

value:DBXBTMSZEOQQDU-VKHMYHEASA-N

source:ChemAxon

14:

kind:polar_surface_area

value:57.53

source:ChemAxon

15:

kind:refractivity

value:23.62

source:ChemAxon

16:

kind:polarizability

value:9.98

source:ChemAxon

17:

kind:rotatable_bond_count

value:2

source:ChemAxon

18:

kind:acceptor_count

value:3

source:ChemAxon

19:

kind:donor_count

value:2

source:ChemAxon

20:

kind:physiological_charge

value:-1

source:ChemAxon

21:

kind:formal_charge

value:0

source:ChemAxon

22:

kind:number_of_rings

value:0

source:ChemAxon

23:

kind:bioavailability

value:Yes

source:ChemAxon

24:

kind:rule_of_five

value:Yes

source:ChemAxon

25:

kind:ghose_filter

value:No

source:ChemAxon

26:

kind:veber_rule

value:No

source:ChemAxon

27:

kind:mddr_like_rule

value:No

source:ChemAxon

光谱
生物学性质
1:

cellular:(1):Cytoplasm

cellular:(2):Mitochondria

2:

biospecimen:(1):Blood

biospecimen:(2):Cerebrospinal Fluid (CSF)

biospecimen:(3):Feces

biospecimen:(4):Saliva

biospecimen:(5):Urine

3:

4:

[1]:

name:2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency

smpdb_id:SMP00137

kegg_map_id:

[2]:

name:3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency

smpdb_id:SMP00138

kegg_map_id:

[3]:

name:3-hydroxyisobutyric acid dehydrogenase deficiency

smpdb_id:SMP00521

kegg_map_id:

[4]:

name:3-hydroxyisobutyric aciduria

smpdb_id:SMP00522

kegg_map_id:

[5]:

name:3-Methylcrotonyl Coa Carboxylase Deficiency Type I

smpdb_id:SMP00237

kegg_map_id:

[6]:

name:3-Methylglutaconic Aciduria Type I

smpdb_id:SMP00139

kegg_map_id:

[7]:

name:3-Methylglutaconic Aciduria Type III

smpdb_id:SMP00140

kegg_map_id:

[8]:

name:3-Methylglutaconic Aciduria Type IV

smpdb_id:SMP00141

kegg_map_id:

[9]:

name:Beta-Ketothiolase Deficiency

smpdb_id:SMP00173

kegg_map_id:

[10]:

name:Isobutyryl-coa dehydrogenase deficiency

smpdb_id:SMP00523

kegg_map_id:

[11]:

name:Isovaleric acidemia

smpdb_id:SMP00524

kegg_map_id:

[12]:

name:Isovaleric Aciduria

smpdb_id:SMP00238

kegg_map_id:

[13]:

name:Maple Syrup Urine Disease

smpdb_id:SMP00199

kegg_map_id:

[14]:

name:Methylmalonate Semialdehyde Dehydrogenase Deficiency

smpdb_id:SMP00384

kegg_map_id:

[15]:

name:Methylmalonic Aciduria

smpdb_id:SMP00200

kegg_map_id:

[16]:

name:Propionic Acidemia

smpdb_id:SMP00236

kegg_map_id:

[17]:

name:Valine, leucine and isoleucine degradation

smpdb_id:

kegg_map_id:map00280

正常浓度
1:

biospecimen:Blood

concentration_value:21.0 +/- 2.0

concentration_units:uM

subject_age:Adult (>18 years old)

subject_sex:Both

subject_condition:Normal

2:

biospecimen:Blood

concentration_value:20.0 (4.0-48.0)

concentration_units:uM

subject_age:Children (1-13 years old)

subject_sex:Both

subject_condition:Normal

3:

biospecimen:Cerebrospinal Fluid (CSF)

concentration_value:18.0 +/- 18.0 (0 - 36)

concentration_units:uM

subject_age:Adult (>18 years old)

subject_sex:Not Specified

subject_condition:Normal

4:

biospecimen:Feces

concentration_value:

concentration_units:

subject_age:Adult (>18 years old)

subject_sex:Both

subject_condition:Normal

5:

biospecimen:Saliva

concentration_value:1.23 +/- 0.71

concentration_units:uM

subject_age:Adult (>18 years old)

subject_sex:Both

subject_condition:Normal

6:

biospecimen:Urine

concentration_value:29.0 (11.8-59.8)

concentration_units:umol/mmol creatinine

subject_age:Adult (>18 years old)

subject_sex:Both

subject_condition:Normal

7:

biospecimen:Urine

concentration_value:10-17.0

concentration_units:umol/mmol creatinine

subject_age:Infant (0-1 year old)

subject_sex:Male

subject_condition:Normal

8:

biospecimen:Urine

concentration_value:10.0-15.9

concentration_units:umol/mmol creatinine

subject_age:Infant (0-1 year old)

subject_sex:Female

subject_condition:Normal

9:

biospecimen:Urine

concentration_value:6.9-13.4

concentration_units:umol/mmol creatinine

subject_age:Infant (0-1 year old)

subject_sex:Female

subject_condition:Normal

10:

biospecimen:Urine

concentration_value:8.1-18

concentration_units:umol/mmol creatinine

subject_age:Infant (0-1 year old)

subject_sex:Male

subject_condition:Normal

11:

biospecimen:Urine

concentration_value:13.39 +/- 6.588

concentration_units:umol/mmol creatinine

subject_age:Children (1 - 13 years old)

subject_sex:Not Specified

subject_condition:Normal

12:

biospecimen:Urine

concentration_value:13.0 (2.0-24.0)

concentration_units:umol/mmol creatinine

subject_age:Children (1-13 years old)

subject_sex:Both

subject_condition:Normal

13:

biospecimen:Urine

concentration_value:11 (4.1-19)

concentration_units:umol/mmol creatinine

subject_age:Adult (>18 years old)

subject_sex:Both

subject_condition:Normal

14:

biospecimen:Urine

concentration_value:<95

concentration_units:umol/mmol creatinine

subject_age:Children (1 - 18 years old)

subject_sex:Both

subject_condition:Normal

15:

biospecimen:Urine

concentration_value:14.5 (5.5-28.7)

concentration_units:umol/mmol creatinine

subject_age:Newborn (0-30 days old)

subject_sex:Both

subject_condition:Normal

16:

biospecimen:Urine

concentration_value:8.5 (4.9-17.1)

concentration_units:umol/mmol creatinine

subject_age:Children (1-13 years old)

subject_sex:Both

subject_condition:Normal

17:

biospecimen:Urine

concentration_value:7.8 (3.8-25.1)

concentration_units:umol/mmol creatinine

subject_age:Adolescent (13-18 years old)

subject_sex:Both

subject_condition:Normal

18:

biospecimen:Urine

concentration_value:25.4 (10.2 -33.5)

concentration_units:umol/mmol creatinine

subject_age:Infant (0-1 year old)

subject_sex:Both

subject_condition:Normal

异常浓度
1:

biospecimen:Blood

concentration_value:38.0 +/- 5.0

concentration_units:uM

patient_age:Adult (>18 years old)

patient_sex:Both

patient_information:Diabetes

2:

biospecimen:Feces

concentration_value:

concentration_units:

patient_age:Adult (>18 years old)

patient_sex:Both

patient_information:Colorectal cancer

3:

biospecimen:Feces

concentration_value:

concentration_units:

patient_age:Adult (>18 years old)

patient_sex:Both

patient_information:Colorectal cancer

4:

biospecimen:Urine

concentration_value:12.772 +/- 10.179

concentration_units:umol/mmol creatinine

patient_age:Children (1 - 13 years old)

patient_sex:Not Specified

patient_information:Eosinophilic esophagitis

5:

biospecimen:Urine

concentration_value:17.5 (2.0-33.0)

concentration_units:umol/mmol creatinine

patient_age:Adult (>18 years old)

patient_sex:Both

patient_information:3-Hydroxyisobutyric aciduria

6:

biospecimen:Urine

concentration_value:225.0 (60.0-390.0)

concentration_units:umol/mmol creatinine

patient_age:Children (1-13 years old)

patient_sex:Both

patient_information:3-Hydroxyisobutyric Aciduria

疾病参考
1:

name:Diabetes mellitus type 2

omim_id:125853

[1]:

reference_text:Tuma P, Samcova E, Balinova P: Determination of 3-methylhistidine and 1-methylhistidine in untreated urine samples by capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Jul 5;821(1):53-9.

pubmed_id:15899597

[2]:

reference_text:Costa A, Iguala I, Bedini J, Quinto L, Conget I: Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism. 2002 Mar;51(3):372-5.

pubmed_id:11887176

[3]:

reference_text:Dungan KM, Buse JB, Largay J, Kelly MM, Button EA, Kato S, Wittlin S: 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes. Diabetes Care. 2006 Jun;29(6):1214-9.

pubmed_id:16731998

[4]:

reference_text:Sheikh-Ali M, Karon BS, Basu A, Kudva YC, Muller LA, Xu J, Schwenk WF, Miles JM: Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis? Diabetes Care. 2008 Apr;31(4):643-7. doi: 10.2337/dc07-1683. Epub 2008 Jan 9.

pubmed_id:18184896

[5]:

reference_text:Tasker RC, Lutman D, Peters MJ: Hyperventilation in severe diabetic ketoacidosis. Pediatr Crit Care Med. 2005 Jul;6(4):405-11.

pubmed_id:15982426

[6]:

reference_text:Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ: Use of high-resolution proton nuclear magnetic resonance spectroscopy for rapid multi-component analysis of urine. Clin Chem. 1984 Mar;30(3):426-32.

pubmed_id:6321058

[7]:

reference_text:Wahl HG, Hoffmann A, Luft D, Liebich HM: Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A. 1999 Jun 25;847(1-2):117-25.

pubmed_id:10431355

[8]:

reference_text:Hoppel CL, Genuth SM: Urinary excretion of acetylcarnitine during human diabetic and fasting ketosis. Am J Physiol. 1982 Aug;243(2):E168-72.

pubmed_id:6810706

[9]:

reference_text:Zhang AQ, Mitchell SC, Smith RL: Dimethylamine in human urine. Clin Chim Acta. 1995 Jan 16;233(1-2):81-8.

pubmed_id:7758205

[10]:

reference_text:Stickle D, Turk J: A kinetic mass balance model for 1,5-anhydroglucitol: applications to monitoring of glycemic control. Am J Physiol. 1997 Oct;273(4 Pt 1):E821-30.

pubmed_id:9357814

[11]:

reference_text:del Carmen Crespillo M, Olveira G, de Adana MS, Rojo-Martinez G, Garcia-Aleman J, Olvera P, Soriguer F, Munoz A: Metabolic effects of an enteral nutrition formula for diabetes: comparison with standard formulas in patients with type 1 diabetes. Clin Nutr. 2003 Oct;22(5):483-7.

pubmed_id:14512036

[12]:

reference_text:Blomqvist G, Alvarsson M, Grill V, Von Heijne G, Ingvar M, Thorell JO, Stone-Elander S, Widen L, Ekberg K: Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients. Am J Physiol Endocrinol Metab. 2002 Jul;283(1):E20-8.

pubmed_id:12067838

[13]:

reference_text:Stupar J, Vrtovec M, Dolinsek F: Longitudinal hair chromium profiles of elderly subjects with normal glucose tolerance and type 2 diabetes mellitus. Metabolism. 2007 Jan;56(1):94-104.

pubmed_id:17161231

[14]:

reference_text:Shin CS, Moon BS, Park KS, Kim SY, Park SJ, Chung MH, Lee HK: Serum 8-hydroxy-guanine levels are increased in diabetic patients. Diabetes Care. 2001 Apr;24(4):733-7.

pubmed_id:11315839

[15]:

reference_text:Nguyen TM, Rodriguez LM, Mason KJ, Heptulla RA: Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus. Pediatr Diabetes. 2007 Aug;8(4):214-9.

pubmed_id:17659063

[16]:

reference_text:Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, Rosenbloom AL: Comparison of oral insulin spray and subcutaneous regular insulin at mealtime in type 1 diabetes. Diabetes Technol Ther. 2007 Aug;9(4):372-6.

pubmed_id:17705693

[17]:

reference_text:McLellan AC, Phillips SA, Thornalley PJ: Fluorimetric assay of D-lactate. Anal Biochem. 1992 Oct;206(1):12-6.

pubmed_id:1456422

[18]:

reference_text:Giussi GA, Ballejo G, Benedetti WL: Estriol serum levels, neonatal vitality and stromal villous edema in diabetic pregnancies. Acta Diabetol Lat. 1979 Apr-Jun;16(2):105-10.

pubmed_id:484160

[19]:

reference_text:Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman WR: D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9988-92.

pubmed_id:8234346

[20]:

reference_text:Greco AV, Mingrone G, Capristo E, Benedetti G, De Gaetano A, Gasbarrini G: The metabolic effect of dodecanedioic acid infusion in non-insulin-dependent diabetic patients. Nutrition. 1998 Apr;14(4):351-7.

pubmed_id:9591306

[21]:

reference_text:Mine S, Okada Y, Kawahara C, Tabata T, Tanaka Y: Serum hyaluronan concentration as a marker of angiopathy in patients with diabetes mellitus. Endocr J. 2006 Dec;53(6):761-6. Epub 2006 Sep 12.

pubmed_id:16966827

[22]:

reference_text:Liebich HM, Buelow HJ, Kallmayer R: Quantification of endogenous aliphatic alcohols in serum and urine. J Chromatogr. 1982 Apr 30;239:343-9.

pubmed_id:7096503

[23]:

reference_text:Avogaro A, Bier DM: Contribution of 3-hydroxyisobutyrate to the measurement of 3-hydroxybutyrate in human plasma: comparison of enzymatic and gas-liquid chromatography-mass spectrometry assays in normal and in diabetic subjects. J Lipid Res. 1989 Nov;30(11):1811-7.

pubmed_id:2614280

[24]:

reference_text:Khuhawar MY, Zardari LA, Laghari AJ: Capillary gas chromatographic determination of methylglyoxal from serum of diabetic patients by precolumn derivatization with 1,2-diamonopropane. J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):15-9. doi: 10.1016/j.jchromb.2008.04.048. Epub 2008 May 17.

pubmed_id:18760976

[25]:

reference_text:Kawasaki T, Akanuma H, Yamanouchi T: Increased fructose concentrations in blood and urine in patients with diabetes. Diabetes Care. 2002 Feb;25(2):353-7.

pubmed_id:11815509

[26]:

reference_text:Noroozi M, Burns J, Crozier A, Kelly IE, Lean ME: Prediction of dietary flavonol consumption from fasting plasma concentration or urinary excretion. Eur J Clin Nutr. 2000 Feb;54(2):143-9.

pubmed_id:10694785

[27]:

reference_text:Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A: Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem. 2007 Dec;40(18):1398-405. Epub 2007 Aug 10.

pubmed_id:17919531

[28]:

reference_text:Salek RM, Maguire ML, Bentley E, Rubtsov DV, Hough T, Cheeseman M, Nunez D, Sweatman BC, Haselden JN, Cox RD, Connor SC, Griffin JL: A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human. Physiol Genomics. 2007 Apr 24;29(2):99-108. Epub 2006 Dec 26.

pubmed_id:17190852

[29]:

reference_text:Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, Scanlan TS, Iervasi G, Zucchi R: Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab. 2012 Jan;97(1):E69-74. doi: 10.1210/jc.2011-1115. Epub 2011 Oct 26.

pubmed_id:22031514

[30]:

reference_text:Llorach R, Urpi-Sarda M, Tulipani S, Garcia-Aloy M, Monagas M, Andres-Lacueva C: Metabolomic fingerprint in patients at high risk of cardiovascular disease by cocoa intervention. Mol Nutr Food Res. 2013 Jun;57(6):962-73. doi: 10.1002/mnfr.201200736. Epub 2013 May 2.

pubmed_id:23637065

[31]:

reference_text:World Health Organisation Department of Noncommunicable Disease Surveillance (1999). "Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications"

pubmed_id:

[32]:

reference_text:Rosa Va ́zquez-Fresno et al. An NMR metabolomics approach reveals a combined-biomarkers model in a wine interventional trial with validation in free-living individuals of the PREDIMED study. Metabolomics (2015) 11:797- 806: https://link.springer.com/content/pdf/10.1007/s11306-014-0735-x.pdf

2:

name:Colorectal cancer

omim_id:114500

[1]:

reference_text:Ishiwata S, Itoh K, Yamaguchi T, Ishida N, Mizugaki M: Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. Tohoku J Exp Med. 1995 May;176(1):61-8.

pubmed_id:7482520

[2]:

reference_text:Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B: Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed. 2009 Apr;22(3):342-8. doi: 10.1002/nbm.1345.

pubmed_id:19006102

[3]:

reference_text:Weir TL, Manter DK, Sheflin AM, Barnett BA, Heuberger AL, Ryan EP: Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One. 2013 Aug 6;8(8):e70803. doi: 10.1371/journal.pone.0070803. Print 2013.

pubmed_id:23940645

[4]:

reference_text:Phua LC, Chue XP, Koh PK, Cheah PY, Ho HK, Chan EC: Non-invasive fecal metabonomic detection of colorectal cancer. Cancer Biol Ther. 2014 Apr;15(4):389-97. doi: 10.4161/cbt.27625. Epub 2014 Jan 14.

pubmed_id:24424155

[5]:

reference_text:Ritchie SA, Ahiahonu PW, Jayasinghe D, Heath D, Liu J, Lu Y, Jin W, Kavianpour A, Yamazaki Y, Khan AM, Hossain M, Su-Myat KK, Wood PL, Krenitsky K, Takemasa I, Miyake M, Sekimoto M, Monden M, Matsubara H, Nomura F, Goodenowe DB: Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection. BMC Med. 2010 Feb 15;8:13. doi: 10.1186/1741-7015-8-13.

pubmed_id:20156336

[6]:

reference_text:Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zhao A, Xu LX, Cai S, Jia W: Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009 Oct;8(10):4844-50. doi: 10.1021/pr9004162.

pubmed_id:19678709

[7]:

reference_text:Cheng Y, Xie G, Chen T, Qiu Y, Zou X, Zheng M, Tan B, Feng B, Dong T, He P, Zhao L, Zhao A, Xu LX, Zhang Y, Jia W: Distinct urinary metabolic profile of human colorectal cancer. J Proteome Res. 2012 Feb 3;11(2):1354-63. doi: 10.1021/pr201001a. Epub 2011 Dec 28.

pubmed_id:22148915

[8]:

reference_text:Ni Y, Xie G, Jia W: Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery. J Proteome Res. 2014 Sep 5;13(9):3857-70. doi: 10.1021/pr500443c. Epub 2014 Aug 14.

pubmed_id:25105552

[9]:

reference_text:Ikeda A, Nishiumi S, Shinohara M, Yoshie T, Hatano N, Okuno T, Bamba T, Fukusaki E, Takenawa T, Azuma T, Yoshida M: Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr. 2012 May;26(5):548-58. doi: 10.1002/bmc.1671. Epub 2011 Jul 20.

pubmed_id:21773981

[10]:

reference_text:Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18.

pubmed_id:25037050

[11]:

reference_text:Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016.

pubmed_id:27015276

[12]:

reference_text:Lin Y, Ma C, Liu C, Wang Z, Yang J, Liu X, Shen Z, Wu R: NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer. Oncotarget. 2016 May 17;7(20):29454-64. doi: 10.18632/oncotarget.8762.

pubmed_id:27107423

[13]:

reference_text:Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016.

pubmed_id:27275383

[14]:

reference_text:Wang X, Wang J, Rao B, Deng L: Gut flora profiling and fecal metabolite composition of colorectal cancer patients and healthy individuals. Exp Ther Med. 2017 Jun;13(6):2848-2854. doi: 10.3892/etm.2017.4367. Epub 2017 Apr 20.

pubmed_id:28587349

[15]:

reference_text:Silke Matysik, Caroline Ivanne Le Roy, Gerhard Liebisch, Sandrine Paule Claus. Metabolomics of fecal samples: A practical consideration. Trends in Food Science & Technology. Vol. 57, Part B, Nov. 2016, p.244-255: http://www.sciencedirect.com/science/article/pii/S0924224416301984

3:

name:3-Hydroxyisobutyric aciduria

omim_id:236795

[1]:

reference_text:MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de)

pubmed_id:

4:

name:Eosinophilic esophagitis

omim_id:610247

[1]:

reference_text:Mordechai, Hien, and David S. Wishart

pubmed_id:

KEGG数据库编号
C06001
DrugBank数据库编号
foodb数据库编号
FDB021877
ChemSpider数据库编号
389707
公共化学化合物编号
440873
PDB数据库编号
生物利益的化学实体数据库编号
37373
knapsack数据库编号
维基百科编号
代谢途径的数据库编号
CPD-12175
苯酚资源管理器化合物数据库编号
比格数据库编号
37034
梅林编号
483
虚拟机身份证编号
3HMP
fbonto数据库编号
综合参考
Robison, Robert S.; Doremus, Michael G.L-(+)-b-Hydroxyisobutyric acid by fermentation. U.S. (1986), 5 pp.
一般参考
1:

protein_accession:HMDBP00355

name:Sulfotransferase family cytosolic 2B member 1

uniprot_id:O00204

gene_name:SULT2B1

protein_type:Enzyme

2:

protein_accession:HMDBP00380

name:Peroxisomal bifunctional enzyme

uniprot_id:Q08426

gene_name:EHHADH

protein_type:Unknown

3:

protein_accession:HMDBP00381

name:Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial

uniprot_id:Q16836

gene_name:HADH

protein_type:Unknown

4:

protein_accession:HMDBP00395

name:3-hydroxyisobutyrate dehydrogenase, mitochondrial

uniprot_id:P31937

gene_name:HIBADH

protein_type:Unknown

5:

protein_accession:HMDBP00483

name:UDP-glucuronosyltransferase 1-1

uniprot_id:P22309

gene_name:UGT1A1

protein_type:Enzyme

6:

protein_accession:HMDBP04709

name:3-hydroxyisobutyryl-CoA hydrolase, mitochondrial

uniprot_id:Q6NVY1

gene_name:HIBCH

protein_type:Enzyme

蛋白质结合
1:

reference_text:Yoshida I, Sweetman L, Kulovich S, Nyhan WL, Robinson BH: Effect of lipoic acid in a patient with defective activity of pyruvate dehydrogenase, 2-oxoglutarate dehydrogenase, and branched-chain keto acid dehydrogenase. Pediatr Res. 1990 Jan;27(1):75-9.

pubmed_id:2104971

2:

reference_text:Liebich HM, Dotzauer A, Tetschner B: Gas chromatographic determination of oxo- and hydroxycarboxylic acids in serum and urine of diabetic and normal subjects. J Chromatogr. 1989 May 12;468:157-65.

pubmed_id:2732286

3:

reference_text:Podebrad F, Heil M, Beck T, Mosandl A, Sewell AC, Bohles H: Stereodifferentiation of 3-hydroxyisobutyric- and 3-aminoisobutyric acid in human urine by enantioselective multidimensional capillary gas chromatography-mass spectrometry. Clin Chim Acta. 2000 Feb 25;292(1-2):93-105.

pubmed_id:10686279

4:

reference_text:Chitayat D, Meagher-Villemure K, Mamer OA, O'Gorman A, Hoar DI, Silver K, Scriver CR: Brain dysgenesis and congenital intracerebral calcification associated with 3-hydroxyisobutyric aciduria. J Pediatr. 1992 Jul;121(1):86-9.

pubmed_id:1625099

5:

reference_text:Landaas S: Accumulation of 3-hydroxyisobutyric acid, 2-methyl-3-hydroxybutyric acid and 3-hydroxyisovaleric acid in ketoacidosis. Clin Chim Acta. 1975 Oct 15;64(2):143-54.

pubmed_id:126826

6:

reference_text:Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL: Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis. 1993;16(4):648-69.

pubmed_id:8412012

7:

reference_text:Djoumbou-Feunang Y, Fiamoncini J, Gil-de-la-Fuente A, Greiner R, Manach C, Wishart DS: BioTransformer: a comprehensive computational tool for small molecule metabolism prediction and metabolite identification. J Cheminform. 2019 Jan 5;11(1):2. doi: 10.1186/s13321-018-0324-5.

pubmed_id:30612223

8:

reference_text:Viegas CM, da Costa Ferreira G, Schuck PF, Tonin AM, Zanatta A, de Souza Wyse AT, Dutra-Filho CS, Wannmacher CM, Wajner M: Evidence that 3-hydroxyisobutyric acid inhibits key enzymes of energy metabolism in cerebral cortex of young rats. Int J Dev Neurosci. 2008 May-Jun;26(3-4):293-9. doi: 10.1016/j.ijdevneu.2008.01.007. Epub 2008 Feb 7.

pubmed_id:18329219

免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:国家药品监督管理局| 国家中医药管理局| SDA药品评审中心| 医加医疗器械| 膏药生产厂家| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:33068302000535
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3